Biogen Inc.

Biogen Inc. - Enterprise Valueverified

IDP.DE

Price:

$165.68

Market Cap:

$33.35B

Biogen Inc. is a prominent biopharmaceutical company dedicated to the research, development, production, and commercialization of therapeutic solutions for neurological and neurodegenerative disorders. Its extensive product lineup features treatments for multiple sclerosis (MS), including TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy, the company offers SPINRAZA, and FUMADERM addresses plaque psoriasis. Furthermore, Biogen provides ADUHELM for Alzheimer's disease. The company's portfolio also encompasses various biosimilar products, such as BENEPALI (an etanercept biosimilar referencing ENBREL), IMRALDI (an adalimumab biosimilar referencing HUMIRA),...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2000-01-03

Stock Exchange

XETRA

Ticker

IDP.DE

The Enterprise Value as of October 2026 (TTM) for Biogen Inc. (IDP.DE) is 40.42B

According to Biogen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 40.42B. This represents a change of 32.34% compared to the average of 30.54B of the last 4 quarters.

Biogen Inc. (IDP.DE) Historical Enterprise Value (quarterly & annually)

How has IDP.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Biogen Inc. over the last ten years is 49.40B. The current 40.42B Enterprise Value has changed 8.08% with respect to the historical average. Over the past ten years (40 quarters), IDP.DE's Enterprise Value was at its highest in in the September 2018 quarter at 74.55B. The Enterprise Value was at its lowest in in the June 2025 quarter at 22.16B.

Quarterly (TTM)
Annual

Average

49.40B

Median

44.81B

Minimum

26.54B

Maximum

72.09B

Biogen Inc. (IDP.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biogen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 12.14%

Maximum Annual Enterprise Value = 72.09B

Minimum Annual Increase = -39.32%

Minimum Annual Enterprise Value = 26.54B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202529.76B12.14%
202426.54B-39.32%
202343.73B0.69%
202243.43B5.64%
202141.11B-10.42%
202045.89B-22.17%
201958.97B-11.15%
201866.37B-7.94%
201772.09B9.02%
201666.12B-12.87%

Biogen Inc. (IDP.DE) Average Enterprise Value

How has IDP.DE Enterprise Value performed in the past?

The current Enterprise Value of Biogen Inc. (IDP.DE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

33.34B

5-year avg

36.91B

10-year avg

49.40B

Biogen Inc. (IDP.DE) Enterprise Value vs. Peers

How is IDP.DE’s Enterprise Value compared to its peers?

Biogen Inc.’s Enterprise Value is greater than Genmab A/S (26.27B), less than Coloplast A/S (121.19B), less than Bayer Aktiengesellschaft (77.14B), greater than Fresenius Medical Care AG & Co. KGaA (19.88B), greater than BioNTech SE (11.78B), less than Illumina, Inc. (43.57B), less than Bayer Aktiengesellschaft (77.14B), greater than Koninklijke Philips N.V. (26.96B), greater than Sartorius AG (21.23B), greater than Sartorius AG (21.23B),

Build a custom stock screener for Biogen Inc. (IDP.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biogen Inc. (IDP.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Biogen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Biogen Inc. (IDP.DE)?

What is the 3-year average Enterprise Value for Biogen Inc. (IDP.DE)?

What is the 5-year average Enterprise Value for Biogen Inc. (IDP.DE)?

How does the current Enterprise Value for Biogen Inc. (IDP.DE) compare to its historical average?